Myocardial revascularization in patients with multivessel coronary artery disease and minimal angina pectoris

J Wynne1, L H Cohn, J J Collins

  • 1Department of Medicine, Peter Bent Brigham Hospital, 721 Huntington Avenue, Boston, Massachusetts 02115, USA.

Circulation
|September 1, 1978
PubMed

Insights

Coronary artery bypass surgery may benefit patients with severe coronary artery disease but minimal angina. This study found no operative mortality and a 5.0% cumulative mortality in such patients.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery

Background:

  • Mortality risk in coronary artery disease (CAD) correlates more with coronary obstructions and left ventricular asynergy than angina severity.
  • Coronary revascularization is typically for angina relief, leaving outcomes for asymptomatic severe CAD underreported.

Purpose of the Study:

  • To evaluate the results of coronary artery bypass surgery in patients with anatomically severe coronary artery disease but minimal or no angina pectoris.

Main Methods:

  • Retrospective analysis of 844 patients undergoing coronary artery bypass surgery between July 1970 and December 1976.
  • Focused on a subgroup of 20 patients with severe coronary obstruction and minimal/no angina, identified via coronary arteriography, positive exercise tests, or prior myocardial infarction.

Main Results:

  • No operative mortality was observed in the 20-patient subgroup.
  • A 5.0% cumulative mortality occurred, with one late death 5 years post-surgery.
  • Of 12 patients with pre- and post-operative exercise tests, 8 showed normalization and 4 showed improved exercise tolerance.

Conclusions:

  • Coronary revascularization can be beneficial for patients with "asymptomatic" but anatomically severe coronary artery disease.
  • Surgical intervention may improve objective measures of cardiac function and exercise capacity in this patient group.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...